2025年 新着論文 15 細胞情報学分野から論文が発表されました

The reaction mechanism for glycolysis side product degradation by Parkinson’s disease-linked DJ-1

J Cell Biol. 2025 Aug 4;224(8):e202411078. doi: 10.1083/jcb.202411078. Epub 2025 Jun 4.

Authors

Aiko Watanabe  1 Shizuka Ogiwara  1 Mirei Saito  1 Masaki Mishima  2 Masahiro Yamashina  3 Ryuichiro Ishitani  4 Yutaka Ito  5 Keiji Tanaka  6 Fumika Koyano  1 Koji Yamano  1   7 Hidetaka Kosako  8 Yoshitaka Moriwaki  4 Noriyuki Matsuda  1

Affiliations

  • 1 Department of Biomolecular Pathogenesis, Division of Advanced Pathophysiological Science, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan.
  • 2 Department of Molecular Biophysics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • 3 Department of Chemistry, School of Science, Institute of Science Tokyo, Tokyo, Japan.
  • 4 Department of Computational Drug Discovery and Design, Division of Biological Data Science, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan.
  • 5 Department of Chemistry, Tokyo Metropolitan University, Tokyo, Japan.
  • 6 Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • 7 Intracellular Quality Control Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • 8 Division of Cell Signaling, Fujii Memorial Institute of Medical Sciences, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.

Abstract

DJ-1/PARK7 is the causative gene for hereditary recessive Parkinson’s disease. Recent studies have reported that DJ-1 hydrolyzes cyclic 3-phosphoglyceric anhydride (cPGA), a highly reactive metabolite. However, the molecular mechanisms underlying cPGA hydrolase activity have yet to be fully elucidated. To gain a more comprehensive understanding of this activity in DJ-1, we performed molecular simulations that predicted how DJ-1 recognizes and hydrolyzes cPGA. The accuracy of these structural predictions was validated through systematic mutational analyses exemplified by loss of activity with the A107P mutation. Although DJ-1 possesses both cPGA hydrolase and α-oxoaldehyde hydratase activities in vitro, we confirmed that DJ-1 dysfunction caused an increase in cPGA-derived modifications but had no effect on α-oxoaldehyde-derived modifications in cells. Importantly, A107 and P158, pathogenic missense mutation sites found in Parkinson’s disease patients, are critical for cPGA hydrolysis both in vitro and in cells. The evidence-based catalytic mechanism for DJ-1 hydrolysis of cPGA that we propose here explains their pathophysiological significance.

Conflict of interest statement

Disclosures: The authors declare no competing interests exist.

Full text links